Tianjin Century Healthcare Biomedical Engineering Co., Ltd. (hereinafter referred to as "Century Healthcare") is a Class-III high-end medical device manufacturing enterprise integrating research and development, production, and sales. Century Healthcare is located in the West District of Tianjin Development Zone with a GMP factory area of 20,000m². It established 10,000-level clean production workshop, and high-quality scientific research laboratory equipment with dual water production systems for purified and injection water, as well as an air purification system.
Century Healthcare takes " innovative ophthalmic materials and optical design " as its strategic scope, covering fields such as intraocular lenses, optometry, and biomaterial collagen. After more than 10 years of relentless efforts, Century Healthcare has been awarded "National High-Tech Company", “National 'Specialized, Expert, Unique and Innovative' key Little Giant Company”，"Tianjin Gazelle Company", "Tianjin Strategic Emerging Leading Company", etc. honorary title.It has also been approved for projects such as "Tianjin Key Laboratory of Innovative Ophthalmic Optical Technology", "Graduate Workstation for Industry-Education Integration in Ophthalmology and Optometry", "Tianjin Central Guidance Local Science and Technology Development Fund Project", "Tianjin Major Special Projects in Public Health and Biomedical Technology", "NMED (National Medical Device Innovation Center) 2025 Innovative Medical Device Product Rising Star", and "TOP 100 Comprehensive Strength Ranking of Medical Device R&D in China in 2025". Our company has been selected into the key cultivated listed enterprise database of Binhai New Area,Tianjin.
Century Healthcare adheres to the principle of "focusing on core medical technology and continuously upgrading solutions". Currently, it has over 20 products applied in ophthalmology, surgery, medical aesthetics, and other fields. Our company has obtained over 100 invention patents and utility model patents, 13 NMPA Class III medical device registration certificates, and 4 NMPA Class II medical device registration certificates. In addition, Our company's intraocular lens (IOL) products have also obtained overseas certifications such as CE certification and certification from the Indonesian Ministry of Health. It is currently one of the few domestic enterprises in the ophthalmology field that master core technologies such as optical design, processing, and production of hydrophilic, hydrophobic, single-focus, and multifocal IOLs. Among them, "intelligent targeted light field distribution design", "multi-level depth of focus extension design", "-0.1μm spherical aberration design", "edge-enhanced zero spherical aberration", "hollow haptic", and "625 large optical zone" are all unique designs of domestic IOLs. The innovative medical device product, the trifocal Plus IOL, was launched in January 2025; the second innovative medical device product, the Ultra-EDoF IOL, was approved for marketing in October 2025. Our company has become one of the few domestic manufacturers to obtain "dual innovation" medical device certifications for the aforementioned two high-end lenses. In the field of optometry, defocus lenses, RGP, second-generation aspherical scleral lenses, and OK lenses have all been launched. The collagen sponge product has obtained a new generation of Class III medical device registration certificate for full surgical use under the new standards approved by the National Medical Products Administration since 2011. At the same time, Our company is also one of the few domestic enterprises that possess implant-grade collagen raw materials and cover a full range of products in surgery, medical aesthetics for skin, and functional skincare.
Century Healthcare currently has five wholly-owned subsidiaries responsible for the research and development, production, sales, and other related services of Century Healthcare's products.
Since the launch of the company's independently developed intraocular lens product in 2020, it has solved the problem of cataract disease for nearly million people.
Currently, hydrophilic aspherical intraocular lenses and hydrophobic preloaded intraocular lenses have won the bid for the fourth batch of centralized procurement of medical consumables organized by the state. The products are used in nearly 2,000 hospitals across the country, with a good market reputation and extensive clinical applications.
Class III high-end medical device manufacturer that integrate research and development, production, and sales
Vision, mission, values, and business philosophy
On January 6, 2024, the industrial construction project (Phase II) factory completed acceptance inspection.
On January 16, 2024, Century Healthcare was listed for the first time on the "2023 Venture50 Investment Life and Health Enterprises" list.
In February 2024, Century Healthcare participated in APAO2024 and launched its international market business expansion officially.
On March 8, 2024, Century Healthcare donated 830 intraocular lenses to support the "Peng Nian Bright Action".
On March 29, 2024, the company and Tanggu Maternity and Gynecology Hospital in Binhai New Area, Tianjin jointly applied for the "Central Guidance for Local Science and Technology Development Fund" project, which was successfully completed.
On April 19, 2024, depth of field extended intraocular lens (EDOF) from the company's independently developed was approved as an innovative medical device.
On July 30, 2024, new generation pre-assembled universal hydrophobic intraocular lens from the company's independently developed was selected for the tenth batch of "Excellent Domestic Medical Equipment Product Catalog".
In August 2024, the Century Healthcare hydrophilic non-spherical intraocular lens was approved by the State Administration for Market Regulation to add negative power, and the optical power range was changed from the original "+5.0D to+30.0D, with an optical power interval of 0.5D" to "-10.0D to+30.0D, with an optical power interval of 0.5D".
On August 22, 2024, we obtained the registration certificate for rigid breathable scleral contact lenses (registration number: 20243161538) .
On September 2, 2024, it was awarded the title of National Specialized, Refined, Unique and New "Little Giant" Enterprise.
In September 2024, Century Healthcare was honored as the drafting unit for the group standard release of the "Corneal Plastic Mirror Fitting Regulations".
On September 22, 2024, the company moved into a new residence and the second phase of the office building was officially put into use.
In November 2024, collagen sponge was added with new specifications specifically for oral, otolaryngology.
In December 2024, the Century Healthcare Multi level Depth of Field Extended intraocular Lens was selected for the Tianjin Science and Technology Major Special Project List.
In April 2023, the joint construction of the Ophthalmology and Ophthalmic Optics Industry Education Integration Graduate Workstation with the Ophthalmology Hospital of Tianjin Medical University was approved.
In April 2023, tens of millions of A+rounds of financing were completed, led by Haihe Industrial Fund.
In April 2023, the wholly-owned subsidiary Century Healthcare (Dongguan) Medical Technology Co., Ltd. was established.
In May 2023, we were awarded the honorary title of Specialized, Refined, Unique, and New Small and Medium sized Enterprise in Tianjin.
In June 2023, the Academic Exchange and Training Base for Grassroots Ophthalmologists jointly established by Tianjin Medical University Ophthalmology Hospital, Tianjin Medical University Ophthalmology Vocational Training School, and Tianjin Century Healthcare Biomedical Engineering Co., Ltd. officially landed.
On July 12, 2023, obtained the registration certificate for hydrophobic aspherical pre installed intraocular lenses (NMPA certificate No.20233160956).
September 2023, hundreds of millions of yuan in Series B financing were completed, led by Guotou Chuanghe Fund.
On October 13, 2023, Century Healthcare 's asymmetric and full field of view multifocal intraocular lens officially entered the special device review process of the National Medical Products Administration for innovation.
On October 23, 2023, obtained the registration certificate for hydrophobic aspherical non pre installed intraocular lenses (NMPA certificate No.20233161502).
On November 30, 2023, Century Healthcare 's intraocular lens won the bid for the fourth batch of national organized procurement of high-value medical consumables.
In November 2023, the "Central Guiding Local Science and Technology Development Fund" innovative ophthalmic materials and optical design technology innovation project was approved.
On December 18, 2023, the collagen dressing produced by Hainan Amily Biotechnology Co.,Ltd, a subsidiary of Century Healthcare, was approved by NMPA .
In May 2022, the wholly-owned subsidiary Century Kangsheng (Shenzhen) Biomedical Engineering Co., Ltd. was established.
In May 2022, tens of millions of A rounds of financing were completed.
In August 2022, the company was listed on the list of "China's 10 fold growth potential medical enterprises" initiated by 36Kr.
In August 2022, it was awarded the title of Excellent Enterprise in the "Maker China" National Biomedical Group Competition and Excellent Enterprise in the Tianjin Division.
In September 2022, it was selected as the second batch of key cultivated listed enterprise reserve resource storage enterprises in Tianjin.
In October 2022, the wholly-owned subsidiary Century Healthcare (Zhuhai Hengqin) Technology Co., Ltd. was established.
In November 2022, the independently developed hydrophilic spherical foldable intraocular lens won the third prize of the Tianjin Science and Technology Progress Award.
In November 2022, the first "Diffractive Multi focus Artificial Lens Project" in China won the first prize in the Biomedical Growth Group of the 2022 Tianjin Innovation and Entrepreneurship Competition and the honorary title of "Excellent Enterprise" in the 11th China Innovation and Entrepreneurship Competition.
In December 2022, the Tianjin Innovative Ophthalmic Optics Technology Key Laboratory, jointly established with the Eye Hospital of Tianjin Medical University, was successfully approved for establishment.
In December 2022, the rigid breathable corneal contact lens was approved for sale with registration (NMPA certificate No. 20223161413).
On January 30, 2021, the industrial transformation cooperation base with the Eye Hospital of Tianjin Medical University was unveiled.
On March 10, 2021, obtained the registration certificate for hydrophilic aspherical intraocular lenses (registration number: NMPA certificate No. 20213160173).
On March 26, 2021, we obtained the third batch of key enterprise qualifications for the "Tianjin Seed" enterprise cultivation plan from the Tianjin Municipal Bureau of Industry and Information Technology and the Tianjin Small and Medium sized Enterprise Credit Financing Guarantee Center, as well as a financing guarantee credit limit of 30 million yuan from the Tianjin Small and Medium sized Enterprise Credit Financing Guarantee Center.
On May 18, 2021, the cosmetics production license was approved, officially entering the field of collagen beauty and skincare.
On July 23, 2021, Hainan Aimei Biotechnology Co., Ltd., a wholly-owned subsidiary, was established.
On August 5, 2021, it was awarded the title of "Specialized, Refined, Unique and New" Seed Enterprise by the Tianjin Municipal Bureau of Industry and Information Technology.
On December 2021, it was selected as a leading enterprise in Tianjin's strategic emerging industries.
On December 2021, it was selected as a "Tianjin Gazelle Enterprise" database.
On January 8, 2020, the wholly-owned subsidiary Century Healthcare (Tianjin) Technology Development Co., Ltd. was established.
On February 12, 2020, obtained the EU CE registration certificate for foldable intraocular lens products.
On March 11, 2020, obtained the collagen sponge registration certificate (NMPA certificate No. 20203140216).
On March 20, 2020, obtained the registration certificate for hydrophilic spherical foldable intraocular lenses (NMPA certificate No. 20203160297).
On April 9, 2020, obtained the registration certificate for disposable ophthalmic surgical knives (NMPA certificate No. 20202160095).
In 2020, hydrophilic spherical foldable intraocular lenses won consecutive bids in the joint volume procurement of medical consumables (artificial lenses) in the Beijing Tianjin Hebei, Heilongjiang Jilin Liaoning Inner Mongolia Shanxi Shandong, and Shaanxi inter provincial alliance, officially entering the centralized procurement sequence of artificial lenses.
In December 2020, we established a comprehensive cooperative relationship with the School of Electronic Information and Optical Engineering of Nankai University, and established an industry university research innovation base.
National High-Tech Company
National "Specialized, Expert, Unique and Innovative" Key Little Giant Company
Tianjin Gazelle Company
Century Healthcare
Meishiji
Ordinary Skincare
